New app aims to help dementia caregivers and prevent neglect
NCT ID NCT07146581
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is developing and testing a screening tool for primary care doctors to spot signs of neglect in older adults with dementia, along with a mobile app called SIRENS that provides caregivers with expert-reviewed information and goal-setting features. The current phase will enroll 40 caregivers to evaluate how usable and acceptable the app is. The goal is to eventually run a larger trial comparing the screening tool alone, the tool plus the app, and standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SIRENS mobile app and screening tool
What this could lead to
If successful, this could provide a practical way for doctors to identify caregiver strain and offer targeted support, potentially reducing elder neglect.
What could go wrong
This is a small, early-stage pilot study with only 40 participants, so results may not apply broadly. The app's effectiveness depends on caregiver engagement and technology access.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact